RxDoctor Payments DataLook up a doctor →

Jim Cheung, MD

Clinical Cardiac Electrophysiology · New York, NYNPI 1366489700

Payments from drug & device makers

$779,952in general payments, 2019–2025

Across 300 payments — averaging $2599.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$402K
  • Medtronic$191K
  • Adagio Medical, Inc.$122K
  • Abbott$35K
  • Biotronik Inc.$17K
  • Biosense Webster, Inc.$7K
  • plus $5K from 6 others
$1,200in research payments, 2019–2025

Across 2 payments — averaging $600.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biotronik Inc.$1K

What the payments were for

  • Consulting fees$30,75527%
  • Speaking & faculty fees$64,67556%
  • Grants$7501%
  • Travel & lodging$12,61311%
  • Food & beverage$6,8776%
  • Education$3580%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$779,952 in reported general payments places this provider in the 90th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York

Medicare billing

Part B allowed, 2024
$390,504
Medicare patients
779
Services billed
3,056

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban168$202,279
MultaqDronedarone Hcl29$37,940
XareltoRivaroxaban23$29,596
Dofetilide43$6,139
Propafenone Hcl ErPropafenone Hcl14$2,535
Amiodarone Hcl46$1,974
Metoprolol Succinate93$1,518

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →